Tight glycemic control may have limited effect on the protection of renal function. No large clinical trials conducted since 2000 have clearly shown that the management goal of HbA1C is 6% better than 7%. In addition, recent clinical trials of many new drugs have compared the HbA1c levels of 8% and 7% groups. Therefore, in this study, HbA1C was divided into each stratum by 1%, and the effect of HbA1c level on renal function was examined. This single-center retrospective observational study examined the HbA1C and Cr data of patients for five consecutive years between 2007 and 2017, beginning from the date of the first measurement of HbA1C. Annual mean values were used as representative values for blood tests. Considering the possibility of a high HbA1C level in the first year, the mean HbA1C level after year 2 was calculated, and the four groups (6%, 7%, 8% and 9%) were compared. Primary endpoints were mean estimated glomerular filtration rate (eGFR) slope and the proportion of patients with rapid renal insufficiency (≥ 5 mL/min/1.73 m2/year). Dialysis patients and those aged 18 years or younger were excluded from the study. The HbA1C 6%, 7%, 8% and 9% groups consisted of 630, 399, 95, and 23 subjects, respectively. The mean ages of these groups were 64.6, 65.0, 60.6, and 61.0 years, respectively, and the mean HbA1C during the course was 6.5 ± 0.3, 7.4 ± 0.3, 8.4 ± 0.3, and 9.4 ± 0.3, respectively. The mean eGFR at 1 year was 69.6, 70.7, 75.7, and 78.4 ml/min/1.73 m2, respectively. The higher the HbA1C level, the greater was the eGFR slope. The eGFR slopes were -1.2 ± 2.8, 1.2 ± 2.7, 1.5 ± 3.3, and 2.6 ± 3.6 mL/min/1.73 m2/year for the four groups, respectively. The incidence of rapid decreased renal function was 7.3%, 6.5%, 10.5% and 21.7% for HbA1C 6%, 7%, 8% and 9% groups, respectively, showing similar tendency with the eGFR slope. Furthermore, only the 6% and 7% groups were analyzed by matching background factors, but no significant difference was found (P = 0.74). In the present study, there was no significant difference in either the eGFR slope or the percentage of patients with rapid decreased renal function between HbA1C in the 6% and 7% ranges.
Read full abstract